Acute erosive gastritis caused by drugs, radiation, infection, or direct trauma.
Reactive gastropathy may be due to bile reflux, particularly after partial gastrectomy.
Portal hypertensive gastropathy, which results in increased friability of gastric mucosa in patients with cirrhosis.[5][6]
Dieulafoy lesions
Dilated aberrant submucosal vessels that erode the overlying epithelium in the absence of an ulcer
Gastric varices
Gastric antral vascular ectasia
Dilated gastric vessels of unknown etiology that cause chronic UGIB and iron-deficiency anemia
Rare causes
Hemobilia, or bleeding from the hepatobiliary tract, most commonly secondary to liver or biliary tract injury, from trauma or following procedures or surgery. Classically accompanied by upper abdominal pain and jaundice. Diagnosed by endoscopic retrograde cholangiopancreatography (ERCP) and treated with arteriography
Aortoenteric fistulas, usually involving the lower duodenum, are secondary to aortic aneurysms or prosthetic vascular grafts; syphilis and tuberculosis are common causes in developing countries. Presents with frank UGIB along with a pulsatile mass and abdominal pain radiating to the back. Diagnosed by endoscopy. Very high morality rate despite surgical repair
Crohn disease involving the upper gastrointestinal tract
Metastatic malignancy involving the upper gastrointestinal tract, such as melanoma or renal cell carcinoma
Hemosuccus pancreaticus
Pancreatic inflammation or cancer may result in bleeding into the pancreatic duct, which connects to the duodenum
NSAID or aspirin use in patients with a history of ulcer disease
Those on dual antiplatelet therapy; those on anticoagulant therapy; or those with two or more of the following risk factors
Age 60 years or older
Glucocorticoid use
Dyspepsia
Gastroesophageal reflux disease
Critical illness
Nosocomial stress ulcers due the to the use of mechanical ventilation for more than 48 hours, and coagulopathy
Other risk factors for nosocomial stress ulcerations in critically ill patients include a history of gastrointestinal ulceration or bleeding within the past year; or two or more of the following risk factors: presence of sepsis, ICU admission lasting longer than 1 week, occult gastrointestinal bleeding lasting 6 days or longer, and administration of more than 250 mg of hydrocortisone or equivalent glucocorticoid therapy
Rare conditions associated with gastric acid hypersecretion, such as Zollinger-Ellison syndrome, mastocytosis, or a retained antrum following partial gastrectomy.
Causes of Acute Upper GI bleeding
Esophagus
Esophagitis
Mallory–Weiss tear
Esophageal varices
Esophageal ulcers
Esophageal cancer
Gastric
Gastric ulcer
Gastric cancer
Gastritis
Gastric varices
Portal hypertensive gastropathy
Gastric antral vascular ectasia
Dielafuoy lesions
Duodenal
Duodenal ulcer
Vascular malformations, including aorto-enteric
Fistulae
Bleeding from the bile duct due to
Liver biopsy
Trauma
Arteriovenous malformations
Liver tumors
Associated Conditions
Heyde syndrome, aortic valve stenosis with associated gastrointestinal bleeding thought to be due to acquired reduction of von Willebrand factor.[11]
History
Obtaining the history is the most important aspect of making a diagnosis of upper GI bleed. It provides insight into the cause, precipitating factors and associated comorbid conditions and also helps in determining the severity of the bleed as well as in identifying the potential source of bleed:
History of any liver disease
History of NSAID use
A thorough review of prescription and nonprescription medications
↑Pilotto A, Franceschi M, Leandro G, Paris F, Niro V, Longo MG, D'Ambrosio LP, Andriulli A, Di Mario F (2003). "The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs". Aging Clin Exp Res. 15 (6): 494–9. PMID14959953.
↑van Leerdam ME (2008). "Epidemiology of acute upper gastrointestinal bleeding". Best Pract Res Clin Gastroenterol. 22 (2): 209–24. doi:10.1016/j.bpg.2007.10.011. PMID18346679.
↑Morales Uribe CH, Sierra Sierra S, Hernández Hernández AM, Arango Durango AF, López GA (2011). "Upper gastrointestinal bleeding: risk factors for mortality in two urban centres in Latin America". Rev Esp Enferm Dig. 103 (1): 20–4. PMID21341933.
↑Rodríguez-Hernández H, Rodríguez-Morán M, González JL, Jáquez-Quintana JO, Rodríguez-Acosta ED, Sosa-Tinoco E, Guerrero-Romero F (2009). "[Risk factors associated with upper gastrointestinal bleeding and with mortality]". Rev Med Inst Mex Seguro Soc (in Spanish; Castilian). 47 (2): 179–84. PMID19744387.CS1 maint: Unrecognized language (link)
↑Corzo Maldonado MA, Guzmán Rojas P, Bravo Paredes EA, Gallegos López RC, Huerta Mercado-Tenorio J, Surco Ochoa Y, Prochazka Zárate R, Piscoya Rivera A, Pinto Valdivia J, De los Ríos Senmache R (2013). "[Risk factors associated to mortality by upper GI bleeding in patients from a public hospital. A case control study]". Rev Gastroenterol Peru (in Spanish; Castilian). 33 (3): 223–9. PMID24108375.CS1 maint: Unrecognized language (link)
↑Soldatov IB, Tokman AS, Esipovich I (1967). "[On the forms of dissemination of advanced experience of otorhinolaryngologists in dispensary work]". Zdravookhr Ross Fed (in Russian). 11 (4): 19–21. PMID5192276. Vancouver style error: initials (help)CS1 maint: Unrecognized language (link)